論文・総説

​

・Liu Q., Li W., Nagata K., Fu H., Okada S., Tanabe I., Kobori Y., Higai K., Norie W., Sasaki T., Asada Y., Zhao H., Bai H., Koike K.： Isolation, Structural Elucidation, and Liquid Chromatography–Mass Spectrometry Analysis of Steroidal Glycosides from Polygonatum odoratum, J. Agric. Food Chem., 66(2) 521-531, 2018. 

 

・Chino D., Sone T., Yamazaki K., Tsuruoka Y., Yamagishi R., Shiina S., Obara K., Yamaki F., Higai K., Tanaka Y., Pharmacological identification of β-adrenoceptor subtypes mediating  　isoprenaline-induced relaxation of guinea pig colonic longitudinal smooth muscle, J. Smooth Muscle Res. 54: 13–27, 2018. 

​

 

・Zhang J., Li W., Sasaki T. Nagata K., Higai K., Feng F., Wang J., Cheng M., Koike K.: Identification of caffeoylquinic acid derivatives as natural protein tyrosine phosphatase 1B inhibitors from Artemisia princeps, Bioorganic & Medicinal Chemistry Letters, 28(7), 1194-1197, 2018. 

 

・ Kobayashi K., Higai K., Matsuo K.,　Bannai Y.,, Horie H., Otakara Y., Li W., Koike K., Yanagino S., Watanabe K., Yoshio T., Wakui N., Nagai H.: Quantitative measurements of sorafenib in patients with advanced hepatocellular carcinoma. International Journal of Research Studies in Medical and Health Sciences, 3(2), 14-19, 2018.

 

・Higai K., Otsuka N., Tanaka Y., Matsumoto K., Matsui M., Yanai K., Wakui N., Nagai H.: Sorafenib Decreases Dihydropyrimidine Dehydrogenase Gene Expression in Hepatocellular Carcinoma HepG2 Cells. Austin J Pharmacol Ther. 6(1).1102, 2018.

 

・Ito K., Kawana M., Iwata T., Higai K.: Transcriptional Regulation of the Natural Cytotoxicity Receptor NKp44 Gene in Human NK cell Leukemia. J of Glycomics Lipidomics 7:1, 2018.

 

・Ito K., Shiraishi R., Higai K.: Globo-A binds to the recombinant natural cytotoxicity receptor NKp44 Biol. Pharm. Bull., 41, 1480-1484, 2018.